Physician profile
Ning Zhong
NPI 1376772244
$3,317.63
in general payments reported to CMS, 2019-2025
9 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2021: $34.82 · 2022: $238 · 2023: $1,051 · 2024: $1,264 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,011 · Travel and Lodging: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,010.56 |
| Travel and Lodging | $699.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $2,095.52 | 2019-2025 | |
| Sk Life Science, INC. | $517.53 | 2024-2025 | Xcopri |
| Medtronic, INC. | $204.10 | 2023 | Interstim, Percept PC Brainsense |
| Medtronic USA, INC. | $178.27 | 2019 | |
| Livanova USA, INC. | $108.19 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Zimmer Biomet Holdings, INC. | $92.88 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $45.83 | 2024 | |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Monteris Medical Corporation | $34.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ning Zhong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.